Treatment Outcome of Palliative Chemotherapy in Inoperable Cholangiocarcinoma in Thailand |
Butthongkomvong, Kritiya
(Medical Oncology Unit, Udonthani Cancer Hospital)
Sirachainan, Ekaphop (Medical Oncology Unit, Ramathibodi Hospital) Jhankumpha, Supattra (Medical Oncology Unit, Udonthani Cancer Hospital) Kumdang, Surang (Medical Oncology Unit, Udonthani Cancer Hospital) Sukhontharot, On-Usa (Cancer Registry Unit, Udonthani Cancer Hospital) |
1 | Thongprasert S, Napapan S, Charoentum C, et al (2005). Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann Oncol, 16, 279-81. DOI ScienceOn |
2 | Valle J, Wasan H, John E, et al (2009). Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. Br J Cancer, 101, 621-7. DOI ScienceOn |
3 | Valle J, Wasan H, Palmer DH, et al (2010). Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med, 362, 1273-81. DOI ScienceOn |
4 | Yonemoto N, Furuse J, Okusaka T, et al (2007). A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer. Jpn J Clin Oncol, 37, 843-51. DOI ScienceOn |
5 | Anderson CD, Wright PC, Berlin J, et al (2004). Diagnosis and treatment of cholangiocarcinoma. Oncologist, 9, 43-57. |
6 | Chaiyut C, Thongprasert S, Busyamas C, et al (2007). Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma. World J Gastroenterol, 13, 2852-4. |
7 | Chaiwerawattana A, Sukarayodhin S, Karalak A, et al (2011). Screening, diagnosis and treatment of liver cancer and bile duct cancer. 2nd ed. National cancer Institute, Thailand |
8 | de Groen PC, Gores GJ, LaRusso NF, et al (1999). Biliary tract cancers. N Engl J Med, 341, 1368-78. DOI ScienceOn |
9 | Hezel AF, Zhu AX (2008). Systemic therapy for biliary tract cancers. Oncologist, 13, 415-23. DOI ScienceOn |
10 | Glimelius B, Hoffman K, Sjoden P-O, et al (1996). Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol, 7, 593-600. DOI ScienceOn |
11 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
12 | Jongha P, Myung-Hwan K, Kyu-pyo Kim, et al (2009). Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study. Gut Liver, 3, 298-305. DOI ScienceOn |
13 | Khan SA, Davidson BR, Goldin R, et al (2002). Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut, 51, 1-9. DOI |
14 | Khuhaprema T, Srivatanakul P, Attasara P, et al (2010). Cancer incidence in Thailand, liver and bile duct. Cancer in Thailand, 5, 31-4 |
15 | Khuntikao N (2005). Current concept in management of cholangiocarcinoma. Srinagarind Med J, 20, 143-9. |
16 | Murad A, Mark JW, Michele M (2009). Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol, 15, 4240-62. DOI ScienceOn |
17 | Sararat C (2010). Hospital based cancer registry 2009. Cancer registry unit, Udonthani cancer center, Thailand |
18 | Siegel R, Naishadham D, Jemal A(2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. DOI ScienceOn |
19 | Thongprasert S (2005). The role of chemotherapy in cholangiocarcinoma. Ann Oncol, 16, 93-6. |
![]() |